OSF Healthcare's investment arm and an unnamed corporate backer both contributed to the heart patient monitor developer's latest round.

US-based patient management technology developer Endotronix closed a $32m series C round yesterday with participation from OSF Ventures, the corporate venturing division of healthcare corporation OSF Healthcare.

The round also featured another, undisclosed strategic corporate investor, as well as BioVentures Investors, SV Life Sciences, Lumira Capital, Aperture Venture Partners and unnamed existing shareholders.

Founded in 2007, Endotronix operates a cloud-based patient management system that connects to an implantable pulmonary artery sensor. The technology enables real-time monitoring of heart failure…